Gilead Sciences
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
22.7421.1814.6513.73
Price/Sales ratio
5.275.134.954.75
Earnings per Share (EPS)
$5.17$5.55$8.02$8.56

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
11.858.187.1020.2314.8815.32822.8414.6523.4617.84931.3914.88
Price/Sales ratio
5.764.533.153.583.663.672.963.333.943.724.143.66
Price/Book Value ratio
9.067.754.954.563.773.644.014.325.084.426.353.77
Price/Cash Flow ratio
11.197.285.757.869.669.028.968.0111.8712.6211.709.66
Price/Free Cash Flow ratio
11.707.566.028.2810.869.929.748.4412.9113.6212.4310.86
Price/Earnings Growth ratio
0.040.14-0.38-0.310.7916.08-8.360.00-0.890.74440.080.79
Dividend Yield
N/A1.26%2.56%2.91%3.65%3.90%4.70%3.95%3.44%3.76%3.27%3.90%
Profitability Indicator Ratios
Gross Profit Margin
84.78%87.72%85.97%83.25%78.06%79.17%81.48%75.82%79.26%76.03%77.98%79.17%
Operating Profit Margin
61.32%67.99%58.02%54.10%37.05%19.09%28.47%27.12%26.86%28.04%29.63%29.63%
Pretax Profit Margin
59.68%66.35%56.25%51.82%35.24%22.98%6.76%30.31%21.31%25.29%0.62%22.98%
Net Profit Margin
48.61%55.47%44.42%17.72%24.65%23.99%0.36%22.79%16.83%20.89%0.44%23.99%
Effective Tax Rate
18.82%16.40%21.10%65.67%29.99%-3.95%94.66%25.09%21.46%18.18%35.22%29.99%
Return on Assets
34.90%34.93%23.69%6.58%8.56%8.73%0.13%9.16%7.26%9.11%0.23%8.73%
Return On Equity
76.49%94.74%69.72%22.57%25.33%23.77%0.48%29.55%21.65%24.81%0.65%23.77%
Return on Capital Employed
52.55%52.90%36.92%24.08%15.45%8.26%12.32%13.14%14.11%14.95%19.58%15.45%
Liquidity Ratios
Current Ratio
3.072.502.212.733.373.101.40N/AN/AN/A1.263.10
Quick Ratio
2.913.244.003.483.283.011.121.061.101.261.103.01
Cash ratio
1.781.290.890.651.691.190.520.450.480.530.421.19
Days of Sales Outstanding
67.9765.4654.2153.8454.8858.2472.3260.0663.9162.7259.1754.88
Days of Inventory outstanding
133.55178.12135.9466.8861.22161.38240.61151.17181.95100.37109.561.22
Operating Cycle
201.52243.59190.15120.72116.10219.62312.94211.23245.86163.10168.67116.10
Days of Payables Outstanding
92.02107.33103.3067.9759.4155.6667.3738.9858.3930.8952.9055.66
Cash Conversion Cycle
109.49136.2586.8552.7556.68163.95245.56172.25187.47132.21115.7656.68
Debt Ratios
Debt Ratio
0.350.420.460.470.420.390.450.390.390.400.420.42
Debt Equity Ratio
0.781.151.361.631.261.081.721.261.181.091.251.08
Long-term Debt to Capitalization
0.420.520.570.600.530.490.610.540.510.500.530.53
Total Debt to Capitalization
0.430.530.570.620.550.520.630.550.540.520.550.52
Interest Coverage Ratio
37.0532.2518.2912.637.614.3010.08N/AN/AN/A8.557.61
Cash Flow to Debt Ratio
1.030.920.630.350.300.370.260.420.350.320.430.30
Company Equity Multiplier
2.192.712.943.422.952.723.753.222.972.722.952.72
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.510.620.540.450.370.400.330.410.330.290.350.40
Free Cash Flow / Operating Cash Flow Ratio
0.950.960.950.950.890.900.920.940.910.920.940.89
Cash Flow Coverage Ratio
1.030.920.630.350.300.370.260.420.350.320.430.30
Short Term Coverage Ratio
26.5320.70N/A4.333.053.652.967.503.994.455.533.05
Dividend Payout Ratio
N/A10.34%18.18%59.01%54.46%59.82%3875.28%57.91%80.77%67.23%3862.69%54.46%